Endovascular Therapeutics India Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 29-05-2024
- Paid Up Capital ₹ 4.60 M
as on 29-05-2024
- Company Age 24 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 5.00 M
as on 29-05-2024
- Satisfied Charges ₹ 2.50 Cr
as on 29-05-2024
About Endovascular Therapeutics India
The Company is engaged in the Real Estate And Construction Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 4.60 M.
The company currently has active open charges totaling ₹5.00 M. The company has closed loans amounting to ₹2.50 Cr, as per Ministry of Corporate Affairs (MCA) records.
Mathew Kalarickal, Bina Mathew, and Sam Mathew serve as directors at the Company.
- CIN/LLPIN
U33112MH2000PTC126063
- Company No.
126063
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Apr 2000
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Endovascular Therapeutics India?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mathew Kalarickal  | Director | 27-Aug-2008 | Current |
| Bina Mathew | Director | 27-Aug-2008 | Current |
| Sam Mathew | Director | 26-Aug-2014 | Current |
Financial Performance and Corporate Structure Insights of Endovascular Therapeutics India.
Endovascular Therapeutics India Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Endovascular Therapeutics India?
In 2017, Endovascular Therapeutics India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
South Indian Green Cardamom Company LimitedActive 18 years 7 monthsBina Mathew and Sam Mathew are mutual person
_PRIVATE_LIMITED.webp)
South Indian Cardamom Online Auction Private LimitedActive 3 years 3 monthsMathew Kalarickal is a mutual person
- Golden-Nest Builders Private LimitedActive 21 years 10 months
Mathew Kalarickal, Bina Mathew and 1 more are mutual person
_PRIVATE_LIMITED.webp)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Union Bank Of India Creation Date: 16 Jan 2003 | ₹5.00 M | Open |
Union Bank Of India Creation Date: 21 Nov 2002 | ₹2.50 Cr | Satisfied |
How Many Employees Work at Endovascular Therapeutics India?
Unlock and access historical data on people associated with Endovascular Therapeutics India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Endovascular Therapeutics India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Endovascular Therapeutics India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED.webp){kind=small}
